| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2023 | Mar 15, 2023 | RAPT Therapeutics, Inc. | Director | Buy | 95.0 | +5,000 | 22.22% | ✗ | $97.6K |
| May 10, 2022 | May 12, 2022 | RAPT Therapeutics, Inc. | Director | Buy | 95.0 | +7,000 | 54.24% | ✗ | $77.3K |
| Oct 18, 2021 | Oct 19, 2021 | RAPT Therapeutics, Inc. | Director | Buy | 83.8 | +500 | 4.03% | ✗ | $15.4K |
| Oct 13, 2021 | Oct 15, 2021 | RAPT Therapeutics, Inc. | Director | Buy | 83.8 | +400 | 3.33% | ✗ | $11.9K |
| Aug 23, 2021 | Aug 25, 2021 | RAPT Therapeutics, Inc. | Director | Buy | 95.0 | +2,000 | 19.99% | ✗ | $62.6K |
| Aug 20, 2021 | Aug 23, 2021 | RAPT Therapeutics, Inc. | Director | Buy | 86.3 | +600 | 6.38% | ✗ | $17.7K |
| Jul 7, 2021 | Jul 8, 2021 | RAPT Therapeutics, Inc. | Director | Buy | 91.3 | +1,000 | 11.90% | ✗ | $30.2K |
| Jun 16, 2021 | Jun 21, 2021 | RAPT Therapeutics, Inc. | Director | Buy | 86.3 | +705 | 9.16% | ✗ | $22.2K |
| Apr 13, 2021 | Apr 14, 2021 | RAPT Therapeutics, Inc. | Director | Buy | 91.3 | +700 | 10.00% | ✗ | $13.6K |
| Apr 9, 2021 | Apr 13, 2021 | RAPT Therapeutics, Inc. | Director | Buy | 91.3 | +1,400 | 25.00% | ✗ | $29.5K |
| Nov 19, 2020 | Nov 23, 2020 | RAPT Therapeutics, Inc. | Director | Buy | 91.3 | +1,000 | 21.74% | ✗ | $16.1K |
| Jun 29, 2020 | Oct 16, 2020 | RAPT Therapeutics, Inc. | Director | Buy | 95.0 | +2,650 | 135.90% | ✗ | $69.3K |
| Sep 28, 2020 | Sep 29, 2020 | RAPT Therapeutics, Inc. | Director | Buy | 86.3 | +500 | 8.26% | ✗ | $14.4K |
| Sep 23, 2020 | Sep 24, 2020 | RAPT Therapeutics, Inc. | Director | Buy | 91.3 | +600 | 11.01% | ✗ | $17.3K |
| Jul 24, 2020 | Jul 27, 2020 | RAPT Therapeutics, Inc. | Director | Buy | 91.3 | +900 | 19.78% | ✗ | $20.2K |
| Jun 29, 2020 | Jul 1, 2020 | RAPT Therapeutics, Inc. | Director | Buy | 95.0 | +2,600 | 133.33% | ✗ | $67.6K |
| Oct 31, 2019 | Jan 17, 2020 | RAPT Therapeutics, Inc. | Director | Buy | 90.0 | +350 | 21.88% | ✗ | $7.6K |
| Nov 4, 2019 | Nov 4, 2019 | RAPT Therapeutics, Inc. | Director | Buy | 91.3 | +1,600 | 100.00% | ✗ | $19.2K |